HIV Vaccine Trials Unit (HVTU)
HVTN 906 - An observational study of women at high risk of becoming HIV infected. (For more information, click here.)
HVTN 080 - A Phase I study to evaluate the safety of a new, experimental HIV vaccine developed at the University of Pennsylvania known as PENNVAX (same product as HVTN 070). The vaccine will be administered in this study with a novel technique known as electroporation.
HVTN 505 - A study of an experimental HIV vaccine in circumcised men who have sex with men. (For more information, click here.)
To make an appointment, or inquire further about our services, please call: 1-866-448-7366.